Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 1444 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 8039 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 8739 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 9171 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 10106 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 14786 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 17379 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 22511 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | 34055 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | PAK | IL-17A | |
Reversed phase NEGATIVE ION MODE | BENZOATE (CAS# 65-85-0); (M-H)- | Peak area | PAK | Untreated |